The biology of cachectin/TNF--a primary mediator of the host response.
暂无分享,去创建一个
B. Beutler | A. Cerami | A Cerami | B Beutler
[1] M. Turner,et al. TUMOUR NECROSIS FACTOR AS AN AUTOCRINE TUMOUR GROWTH FACTOR FOR CHRONIC B-CELL MALIGNANCIES , 1988, The Lancet.
[2] L. F. Fajardo,et al. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. , 1987, Science.
[3] J A Koziol,et al. Evolution of the genome and the genetic code: selection at the dinucleotide level by methylation and polyribonucleotide cleavage. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[4] P. Hotez,et al. Lipoprotein lipase suppression in 3T3‐L1 cells by a haematoprotozoan‐induced mediator from peritoneal exudate cells , 1984, Parasite immunology.
[5] H. Holtmann,et al. Sensitization and desensitization to lethal effects of tumor necrosis factor and IL-1. , 1988, Journal of immunology.
[6] B. Aggarwal,et al. Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors. , 1985, Journal of immunology.
[7] B. Aggarwal,et al. Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. , 1985, Science.
[8] B. Beutler,et al. Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[9] R. Hornung,et al. Target cell DNA fragmentation is mediated by lymphotoxin and tumor necrosis factor. , 1987, Lymphokine research.
[10] D. Kufe,et al. Expression of tumor necrosis factor receptors on human monocytes and internalization of receptor bound ligand. , 1987, Journal of immunology.
[11] K. Manogue,et al. Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. , 1988, Science.
[12] Z. Darżynkiewicz,et al. Cell cycle-specific effects of tumor necrosis factor. , 1984, Cancer research.
[13] G. Trinchieri,et al. Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes , 1987, The Journal of experimental medicine.
[14] A. Cerami,et al. Effect of endotoxin-induced monokines on glucose metabolism in the muscle cell line L6. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[15] T. Decker,et al. Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages. , 1987, Journal of immunology.
[16] P. Cuatrecasas,et al. Cellular receptor for 125I-labeled tumor necrosis factor: specific binding, affinity labeling, and relationship to sensitivity. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[17] H. Northoff,et al. Endotoxic activities of tumor necrosis factor independent of IL1 secretion by macrophages/monocytes. , 1987, Lymphokine research.
[18] J. Abbott,et al. Ontogeny of murine T lymphocytes. I. Maturation of thymocytes induced in vitro by tumor necrosis factor-positive serum (TNF+)1,2. , 1981, Cellular immunology.
[19] J. D. Albert,et al. Materials and Methods Brief Definitive Report CACHECTIN/TUMOR NECROSIS FACTOR MEDIATES CHANGES OF SKELETAL MUSCLE PLASMA MEMBRANE POTENTIAL , 2022 .
[20] P. Scheurich,et al. Quantification and characterization of high‐affinity membrane receptors for tumor necrosis factor on human leukemic cell lines , 1986, International journal of cancer.
[21] R. Wallis,et al. Tumor necrosis factor is the major monocyte product that increases complement receptor expression on mature human neutrophils. , 1988, Blood.
[22] N. Matthews. Tumour-necrosis factor from the rabbit. II. Production by monocytes. , 1978, British Journal of Cancer.
[23] L. Bermudez,et al. Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex. , 1988, Journal of immunology.
[24] A. Oliff,et al. Tumors secreting human TNF/cachectin induce cachexia in mice , 1987, Cell.
[25] H. Holtmann,et al. Binding of human TNF-α to high-affinity cell surface receptors: Effect of IFN , 1986 .
[26] B. Meyrick,et al. Interactions of granulocytes with the lungs. , 1984, Circulation research.
[27] H. Friedman,et al. Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-gamma and tumor necrosis factor. , 1986, Journal of immunology.
[28] J. Vilček,et al. Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors , 1986, The Journal of experimental medicine.
[29] W. Fiers,et al. Recombinant tumor necrosis factor and immune interferon act singly and in combination to reorganize human vascular endothelial cell monolayers. , 1986, The American journal of pathology.
[30] C. Dinarello,et al. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. , 1986, Science.
[31] A. Cerami,et al. Selective inhibition of synthesis of enzymes for de novo fatty acid biosynthesis by an endotoxin-induced mediator from exudate cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[32] J. D. Albert,et al. Shock and tissue injury induced by recombinant human cachectin. , 1986, Science.
[33] A. Mantovani,et al. Interleukin-1 induces c-fos protooncogene expression in cultured human endothelial cells. , 1988, Biochemical and biophysical research communications.
[34] N. Sato,et al. Actions of tumor necrosis factor on cultured vascular endothelial cells: morphologic modulation, growth inhibition, and cytotoxicity. , 1986, Journal of the National Cancer Institute.
[35] G. Shaw,et al. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation , 1986, Cell.
[36] J. David,et al. Tumor necrosis factor enhances eosinophil toxicity to Schistosoma mansoni larvae. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[37] J. Playfair,et al. Malarial parasites and tumour cells are killed by the same component of tumour necrosis serum. , 1984, Clinical and experimental immunology.
[38] J. Saklatvala. Tumour necrosis factor α stimulates resorption and inhibits synthesis of proteoglycan in cartilage , 1986, Nature.
[39] H. Shin,et al. Tumor necrosis factor-mediated cytotoxicity involves ADP-ribosylation. , 1988, Journal of immunology.
[40] L. Chedid,et al. Enhancement of resistance to infections by endotoxin-induced serum factor from Mycobacterium bovis BCG-infected mice , 1980, Infection and immunity.
[41] C. Galanos,et al. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice , 1987, The Journal of experimental medicine.
[42] J. Coalson,et al. Significance of leukocytes in endotoxic shock. , 1974, Experimental and molecular pathology.
[43] W. Fiers,et al. The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygenase inhibitors. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[44] I. Clark,et al. Possible roles of tumor necrosis factor in the pathology of malaria. , 1987, The American journal of pathology.
[45] T. Niijima,et al. Cytotoxic effect of tumor necrosis factor on human lymphocytes and specific binding of the factor to the target cells. , 1983, Cellular and molecular biology.
[46] J. Tavernier,et al. EVIDENCE FOR TUMOUR NECROSIS FACTOR/CACHECTIN PRODUCTION IN CANCER , 1987, The Lancet.
[47] F. Bauss,et al. Tumor necrosis factor mediates endotoxic effects in mice , 1987, Infection and immunity.
[48] H. Koren,et al. Lipopolysaccharide (LPS) stimulates fresh human monocytes to lyse actinomycin D-treated WEHI-164 target cells via increased secretion of a monokine similar to tumor necrosis factor. , 1985, Journal of immunology.
[49] J. Kuhn,et al. Tumor necrosis factor not detectable in patients with clinical cancer cachexia. , 1988, Journal of the National Cancer Institute.
[50] G. Trinchieri,et al. Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon , 1985, The Journal of experimental medicine.
[51] A. Cerami,et al. Lipoprotein lipase suppression in 3T3-L1 cells by an endotoxin-induced mediator from exudate cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[52] J. Gamble,et al. Stimulation of neutrophils by tumor necrosis factor. , 1986, Journal of immunology.
[53] N. Rothwell. Central effects of TNFα on thermogenesis and fever in the rat , 1988, Bioscience reports.
[54] K. Takeda,et al. Identity of differentiation inducing factor and tumour necrosis factor , 1986, Nature.
[55] R L Kassel,et al. An endotoxin-induced serum factor that causes necrosis of tumors. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[56] Kevin J. Tracey,et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia , 1987, Nature.
[57] B. Beutler,et al. A macrophage factor inhibits adipocyte gene expression: an in vitro model of cachexia. , 1985, Science.
[58] B. Waksman,et al. Cytotoxic Effect of Lymphocyte-Antigen Interaction in Delayed Hypersensitivity , 1967, Science.
[59] D. Kufe,et al. Transcriptional and posttranscriptional regulation of tumor necrosis factor gene expression in human monocytes. , 1988, The Journal of clinical investigation.
[60] J. Larrick,et al. Tumor necrosis factor stimulates interleukin-1 and prostaglandin E2 production in resting macrophages. , 1986, Biochemical and biophysical research communications.
[61] A. Waage,et al. ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASE , 1987, The Lancet.
[62] H. Rokita,et al. Limited effects of recombinant human and murine interleukin 1 and tumour necrosis factor on production of acute phase proteins by cultured rat hepatocytes. , 1987, Biochemistry international.
[63] T. Shirai,et al. Cloning and expression in Escherichia coli of the gene for human tumour necrosis factor , 1985, Nature.
[64] B. Beutler,et al. Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells , 1985, The Journal of experimental medicine.
[65] N. Matthews. Tumour-necrosis factor from the rabbit. V. Synthesis in vitro by mononuclear phagocytes from various tissues of normal and BCG-injected rabbits. , 1981, British Journal of Cancer.
[66] B. Beutler,et al. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. , 1985, Science.
[67] J. David,et al. Characterization of a factor from the U937 cell line that enhances the toxicity of human eosinophils to Schistosoma mansoni larvae. , 1987, Journal of Immunology.
[68] P. Ghezzi,et al. Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor , 1988, The Journal of experimental medicine.
[69] J. D. Albert,et al. Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. , 1987, Surgery, gynecology & obstetrics.
[70] B. Beutler,et al. Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo. , 1985, Journal of immunology.
[71] Harold V. Gaskill. Continuous infusion of tumor necrosis factor: mechanisms of toxicity in the rat. , 1988, The Journal of surgical research.
[72] J. Dipersio,et al. Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor. , 1986, Journal of immunology.
[73] H. Ochs,et al. An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukin 1, and tumor necrosis factor-alpha increases neutrophil adherence by a CDw18-dependent mechanism. , 1986, Journal of immunology.
[74] J. Tavernier,et al. Tissue-specific regulation of guinea pig lipoprotein lipase; effects of nutritional state and of tumor necrosis factor on mRNA levels in adipose tissue, heart and liver. , 1988, Gene.
[75] C. Jacob,et al. Tumour necrosis factor-α in murine autoimmune 'lupus' nephritis , 1988, Nature.
[76] J. Playfair,et al. Differential sensitivity in vivo of lethal and nonlethal malarial parasites to endotoxin-induced serum factor , 1982, Infection and immunity.
[77] I. Clark,et al. Macrophages from Babesia and malaria infected mice are primed for monokine release , 1984, Parasite immunology.
[78] J. Haynes,et al. Serum containing tumor necrosis factor is cytotoxic for the human malaria parasite Plasmodium falciparum , 1983, Infection and immunity.
[79] M. Gimbrone,et al. Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. , 1988, The Journal of biological chemistry.
[80] W. Coley,et al. THE TREATMENT OF MALIGNAT TUMORS BY REPEATED INOCULATIONS OF ERYSIPELAS: WITH A REPORT OF TEN ORIGINAL CASES , 1893 .
[81] B. Beutler,et al. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. , 1986, Science.
[82] T. Bringman,et al. Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells. , 1987, The New England journal of medicine.
[83] R. Contreras,et al. The 3' untranslated region of the human interferon-beta mRNA has an inhibitory effect on translation. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[84] B. Aggarwal,et al. Modulation of receptors and cytotoxic response of tumor necrosis factor-alpha by various lectins. , 1986, The Journal of biological chemistry.
[85] D. Goeddel,et al. Cloning and expression in Escherichia coli of the cDNA for murine tumor necrosis factor. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[86] I. Clark. DOES ENDOTOXIN CAUSE BOTH THE DISEASE AND PARASITE DEATH IN ACUTE MALARIA AND BABESIOSIS? , 1978, The Lancet.
[87] B. Aggarwal,et al. Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[88] J. Gamble,et al. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[89] R. Coombes,et al. Changes in thermogenesis and brown fat activity in response to tumour necrosis factor in the rat , 1987, Bioscience reports.
[90] J. Strickler,et al. Molecular cloning of the complementary DNA for human tumor necrosis factor. , 1985, Science.
[91] T. Bringman,et al. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors , 1986, Nature.
[92] S. Natori,et al. Induction of TNF‐like factor by murine macrophage‐like cell line J774.1 on treatment with Sarcophaga lectin , 1984, FEBS letters.
[93] J. Mcghee,et al. The primary role of lymphoreticular cells in the mediation of host responses to bacterial endotoxim. , 1980, The Journal of infectious diseases.
[94] L. Chess,et al. Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1 , 1986, The Journal of experimental medicine.
[95] D. Niederwieser,et al. Interferons (IFNs) and tumor necrosis factors (TNFs) in T cell-mediated immune responses against alloantigens. I. Influence on the activation of resting and antigen-primed T cells. , 1988, Immunobiology.
[96] W. Fiers,et al. Species specificity of human and murine tumor necrosis factor. A comparative study of tumor necrosis factor receptors. , 1986, The Journal of biological chemistry.
[97] M. Kawakami,et al. Human recombinant TNF suppresses lipoprotein lipase activity and stimulates lipolysis in 3T3-L1 cells. , 1987, Journal of biochemistry.
[98] B. Waksman,et al. CYTOTOXICITY MEDIATED BY SOLUBLE ANTIGEN AND LYMPHOCYTES IN DELAYED HYPERSENSITIVITY , 1968, The Journal of experimental medicine.
[99] R. Yamamoto,et al. A high molecular weight component of the human tumor necrosis factor receptor is associated with cytotoxicity. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[100] F. Kraemer,et al. Effects of activation on lipoprotein lipase secretion by macrophages. Evidence for autoregulation , 1986, The Journal of experimental medicine.
[101] J. Playfair,et al. Malarial parasites induce TNF production by macrophages. , 1988, Immunology.
[102] J. Tavernier,et al. Multiple effects of tumor necrosis factor on lipoprotein lipase in vivo. , 1987, The Journal of biological chemistry.
[103] G. Gifford,et al. In vitro production of rabbit macrophage tumor cell cytotoxin , 1983, International journal of cancer.
[104] W. Fiers,et al. Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome , 1986, The Journal of experimental medicine.
[105] D. Rosenstreich,et al. BCG-induced enhancement of endotoxin sensitivity in C3H/HeJ mice. I. In vivo studies. , 1980, Journal of immunology.
[106] J. Playfair,et al. Killing of human malaria parasites by macrophage secretory products , 1984, Infection and immunity.
[107] D. Goeddel,et al. Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes. , 1986, Journal of immunology.
[108] J. Sipe,et al. Tumor necrosis factor/cachectin is a less potent inducer of serum amyloid A synthesis than interleukin 1. , 1987, Lymphokine research.
[109] W. Fiers,et al. Genes for the tumor necrosis factors alpha and beta are linked to the human major histocompatibility complex. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[110] W. Fiers,et al. Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[111] J. Playfair,et al. Endotoxin-induced serum factor kills malarial parasites in vitro , 1981, Infection and immunity.
[112] Murray J. Shear,et al. Chemical Treatment of Tumors. V. Isolation of the Hemorrhage-Producing Fraction from Serratia marcescens (Bacillus prodigiosus) Culture Filtrate , 1943 .
[113] P. Libby,et al. Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. , 1986, The American journal of pathology.
[114] T. Klein,et al. Protective Effects of Tumor Necrosis Factor in Experimental Legionella pneumophila Infections of Mice via Activation of PMN Function , 1988, Journal of leukocyte biology.
[115] M. Mayer,et al. Macrophage-mediated cytotoxicity: role of a soluble macrophage cytotoxic factor similar to lymphotoxin and tumor necrosis factor. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[116] Sergei A. Nedospasov,et al. Nucleotide sequence of the murine TNF locus, including the TNF-α (tumor necrosis factor) and TNF-β (lymphotoxin) genes , 1987 .